Figure 3. Statin Initiations at 12 Months by Study Group and Genotype Among Integrating Pharmacogenetics in Clinical Care Study Participants With Known and Unknown Genotyping Results.

Bars represent percentages of patients with a given genotype and study group assignment who were prescribed statin therapy by 12 months. Among patients whose genotyping results were known at baseline, 45 had the genotype for decreased or poor function and 148 had the genotype for normal function. Among patients whose genotyping results were not known at baseline, 75 had the genotype for decreased or poor function and 140 had the genotype for normal function.